TrueBeam radiotherapy in Turkey typically costs from AUD $5,077 to AUD $10,880. The final price depends on the number of treatment sessions, tumour complexity, and the clinic chosen. Patients save approximately 81% compared to Australia, where the average cost is AUD $42,503. Standard packages usually include treatment planning, radiation sessions, and multilingual patient support in hubs like Istanbul, Ankara, and Bursa.
Bookimed Expert Insight: Choosing a clinic with an academic affiliation provides significant value for Australian patients. For example, Anadolu Medical Center is affiliated with Johns Hopkins Hospital and holds OECI accreditation. This ensures adherence to Western standards at Turkish prices. Specialists like Professor Esra Kaytan Saglam, who has 30+ years of experience, offer expertise that rivals private Australian clinics for a fraction of the cost.
| Turkey | Thailand | ||
| TrueBeam | from AUD $5,077 | from AUD $21,759 | from AUD $4,932 |
Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a fellowship at the prestigious Hacettepe University Cancer Institute. Dr. Solak previously practiced at The University of Texas MD Anderson Cancer Center. He treats a variety of complex cancers, including lung, breast, and gastrointestinal malignancies.
Dr. Esra Kaytan Saglam is a radiation oncologist at Memorial Şişli Hospital in Istanbul. She specializes in TrueBeam technology and stereotaxic radiosurgery for cancer treatment. Dr. Saglam serves as the Chief Editor for the Turkish Society of Oncology. She has authored over 110 scientific publications on various oncological issues.
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.